LD-2 disclosure · 1st Quarter - Report
NOVARTIS, INC.
Client
- Name
- NOVARTIS, INC.
- Description
- ​Multinational biopharmaceutical company.
- Location
- District of Columbia · United States of America
Registrant
- Description
- ​Government Affairs Consulting Firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
Center for Medicare and Medicaid Innovation (CMMI) policy issues. Drug Pricing. General Medicare and Medicaid Issues. H.R.5376 - Inflation Reduction Act of 2022 implementation. S.476 /H.R.5547 - Maintaining Investments in New Innovation Act. S.3131 / H.R.5539 - ORPHAN Cures Act.
LobbyistsDANIEL M TODD · PAUL EDATTEL · JEFF LUCAS · NICHOLAS UEHLECKE · TAYLOR SEXTON · TED LEHMAN · KATHERINE FLEMING COTTON · ERIC BERGREN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Health Issues
Supply Chain. 340B Issues. Outcomes based contracting/value-based arrangements. Genetically Targeted Therapies. Advanced Research Projects Agency for Health funding issues. PBM policy issues. H.R.5376 - Inflation Reduction Act of 2022 implementation.
LobbyistsDANIEL M TODD · PAUL EDATTEL · JEFF LUCAS · NICHOLAS UEHLECKE · TAYLOR SEXTON · TED LEHMAN · KATHERINE FLEMING COTTON · ERIC BERGREN
Covered position (DANIEL M TODD): Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid
Covered position (PAUL EDATTEL): Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
Covered position (JEFF LUCAS): Health Policy Advisor, Senator Bill Cassidy; Legislative Assistant/Sr. Legislative Assistant/Legislative Correspondent, Representative Larry Bucshon